Gene · 1973
Papers1,962
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,962
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| m7G-related gene NUDT4 as a novel biomarker promoting cancer cell proliferation in lung adenocarcinoma. | Front Oncol | 2022 | 36761423 | PubTator, text mining | PubMed |
| Synthetic lethal interactions of DEAD/H-box helicases as targets for cancer therapy. | Front Oncol | 2022 | 36761420 | PubTator, text mining | PubMed |
| Integration of proteomic and metabolomic analyses: New insights for mapping informal workers exposed to potentially toxic elements. | Front Public Health | 2022 | 36761330 | PubTator, text mining | PubMed |
| The role of serine metabolism in lung cancer: From oncogenesis to tumor treatment. | Front Genet | 2022 | 36699468 | PubTator, text mining | PubMed |
| Experimental verification and comprehensive analysis of m7G methylation regulators in the subcluster classification of ischemic stroke. | Front Genet | 2022 | 36685826 | PubTator, text mining | PubMed |
| Alcohol, Resistance Exercise, and mTOR Pathway Signaling: An Evidence-Based Narrative Review. | Biomolecules | 2022 | 36671386 | PubTator, text mining | PubMed |
| SMC4 enhances the chemoresistance of hepatoma cells by promoting autophagy. | Ann Transl Med | 2022 | 36660610 | PubTator, text mining | PubMed |
| Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival. | J Gastrointest Oncol | 2022 | 36636051 | PubTator, text mining | PubMed |
| Comparative analysis of fungal communities between herbicide-resistant and -susceptible Alopecurus aequalis. | Front Cell Infect Microbiol | 2022 | 36619755 | PubTator, text mining | PubMed |
| Reovirus μ2 Protein Impairs Translation to Reduce U5 snRNP Protein Levels. | Int J Mol Sci | 2022 | 36614170 | PubTator, text mining | PubMed |
| Targeting mTORC1 Activity to Improve Efficacy of Radioligand Therapy in Cancer. | Cancers (Basel) | 2022 | 36612012 | PubTator, text mining | PubMed |
| Protocol to analyze dysregulation of the eIF4F complex in human cancers using R software and large public datasets. | STAR Protoc | 2022 | 36595939 | PubTator, text mining | PubMed |
| MATRIX platform to analyze translation machinery remodeling in glioblastoma cells. | STAR Protoc | 2022 | 36595908 | PubTator, text mining | PubMed |
| Signaling pathways of adipose stem cell-derived exosomes promoting muscle regeneration. | Chin Med J (Engl) | 2022 | 36583914 | PubTator, text mining | PubMed |
| The connection between innervation and metabolic rearrangements in pancreatic cancer through serine. | Front Oncol | 2022 | 36582785 | PubTator, text mining | PubMed |
| Native and engineered extracellular vesicles for wound healing. | Front Bioeng Biotechnol | 2022 | 36568307 | PubTator, text mining | PubMed |
Combination Treatment of Withalongolide a Triacetate with Cisplatin Induces Apoptosis by Targeting Translational Initiation, Migration, and Epithelial to Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma. | Nutrients | 2022 | 36558560 | PubTator, text mining | PubMed |
| Real-Time Polymerase Chain Reaction: Current Techniques, Applications, and Role in COVID-19 Diagnosis. | Genes (Basel) | 2022 | 36553654 | PubTator, text mining | PubMed |
| eIF4A/PDCD4 Pathway, a Factor for Doxorubicin Chemoresistance in a Triple-Negative Breast Cancer Cell Model. | Cells | 2022 | 36552834 | PubTator, text mining | PubMed |
| tRFs and tRNA Halves: Novel Cellular Defenders in Multiple Biological Processes. | Curr Issues Mol Biol | 2022 | 36547066 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1973/papers?page=15